Frontier Medicines Announces Oral Presentation on Dual-Acting Inhibitors of the Active and Inactive Forms of KRAS G12C at the American Association for Cancer Research (AACR) Annual Meeting
March 09, 2022 08:00 ET
|
Frontier Medicines
SOUTH SAN FRANCISCO, Calif., March 09, 2022 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthrough therapies against...
Frontier Medicines Announces the Appointment of Monique Bobadilla as Chief People and Culture Officer
March 08, 2022 08:00 ET
|
Frontier Medicines
SOUTH SAN FRANCISCO, Calif., March 08, 2022 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthrough therapies against...
Frontier Medicines Announces Renowned Physician Scientist Piro Lito, M.D., Ph.D., Joins Scientific Advisory Board
February 08, 2022 08:00 ET
|
Frontier Medicines
SOUTH SAN FRANCISCO, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthrough therapies against...
Frontier Medicines Announces Advancement of First Program Under Global Partnership with AbbVie
January 10, 2022 07:00 ET
|
Frontier Medicines
SOUTH SAN FRANCISCO, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise...
Frontier Medicines to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 05, 2022 08:00 ET
|
Frontier Medicines
SOUTH SAN FRANCISCO, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise...
Frontier Medicines to Present at the RBC Capital Markets Healthcare Private Company Virtual Conference
December 09, 2021 08:00 ET
|
Frontier Medicines
SOUTH SAN FRANCISCO, Calif., Dec. 09, 2021 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise...
Frontier Medicines Announces the Appointment of Marguerite Hutchinson, J.D., as Chief Business Officer
November 17, 2021 08:00 ET
|
Frontier Medicines
SOUTH SAN FRANCISCO, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise...
Frontier Medicines to Present at Two Upcoming Investor Conferences in November
November 10, 2021 16:00 ET
|
Frontier Medicines
SOUTH SAN FRANCISCO, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise...
Frontier Medicines to Present at the Cantor Global Healthcare Conference
September 23, 2021 08:00 ET
|
Frontier Medicines
SOUTH SAN FRANCISCO, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise...
Frontier Medicines Raises $88.5 Million Series B Financing to Advance Precision Oncology and Targeted Protein Degradation Pipeline
July 19, 2021 08:00 ET
|
Frontier Medicines
—Funding to Enhance Research and Development of Pipeline, Including Lead Program Targeting Activated KRASG12C— —Proceeds to Further Accelerate the Development of Foundational Technologies in...